These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22658326)

  • 1. Cabergoline associated with first episode mania.
    Harris YT; Harris AZ; Deasis JM; Ferrando SJ; Reddy N; Young RC
    Psychosomatics; 2012; 53(6):595-600. PubMed ID: 22658326
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
    Webster J; Piscitelli G; Polli A; Ferrari CI; Ismail I; Scanlon MF
    N Engl J Med; 1994 Oct; 331(14):904-9. PubMed ID: 7915824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected interaction between quetiapine and valproate in patients with bipolar disorder.
    Huang CC; Wei IH
    Gen Hosp Psychiatry; 2010; 32(4):446.e1-2. PubMed ID: 20633751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperprolactinemic amenorrhea:treatment with cabergoline versus bromocriptine. Results of a national multicenter randomized double-blind study].
    Pascal-Vigneron V; Weryha G; Bosc M; Leclere J
    Presse Med; 1995 Apr; 24(16):753-7. PubMed ID: 7784413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cabergoline and mitral regurgitation.
    Delgrange E
    N Engl J Med; 2006 Jan; 354(4):420; author reply 420. PubMed ID: 16436779
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiopulmonary complications of ergot-derivative dopamine agonists.
    Rack MJ; Baran AS; Richert AC; Roffwarg HP
    J Clin Psychiatry; 2004 Oct; 65(10):1429-30; author reply 1430. PubMed ID: 15491249
    [No Abstract]   [Full Text] [Related]  

  • 7. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AACE/ACE Disease State Clinical Review: Dopamine Agonists for Hyperprolactinemia and the Risk of Cardiac Valve Disease.
    Samson SL; Ezzat S
    Endocr Pract; 2014 Jun; 20(6):608-16. PubMed ID: 24969114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline.
    Moro M; Inada Y; Kojima M; Miyata H; Komatsu H; Torii R
    Eur J Pharmacol; 1999 Feb; 368(1):57-66. PubMed ID: 10096770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment with quetiapine in bipolar disorder patients.
    Basu D; Chakraborty K
    Am J Psychiatry; 2009 Oct; 166(10):1185; author reply 1186-7. PubMed ID: 19797447
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
    Woodward TC; Tafesse E; Quon P; Lazarus A
    Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cabergoline and hyperprolactinaemia: new preparation. Better than bromocriptine.
    Prescrire Int; 2000 Feb; 9(45):195-7. PubMed ID: 11503793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive lamotrigine as a possible mania inducer in bipolar patients.
    Raskin S; Teitelbaum A; Zislin J; Durst R
    Am J Psychiatry; 2006 Jan; 163(1):159-60. PubMed ID: 16390907
    [No Abstract]   [Full Text] [Related]  

  • 14. Mixed episodes with psychotic features.
    Chou JC
    CNS Spectr; 2009 Nov; 14(11 Suppl 11):6-8; discussion 12-4. PubMed ID: 20173694
    [No Abstract]   [Full Text] [Related]  

  • 15. Lesson of the month (1): cabergoline - 'i eat funny on that'.
    Premaratne VS; Saeger I; Macdonald BK
    Clin Med (Lond); 2014 Apr; 14(2):205-7. PubMed ID: 24715137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Paulsson B; Mullen J; Vågerö AM
    J Clin Psychopharmacol; 2004 Dec; 24(6):599-606. PubMed ID: 15538120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
    Mattei AM; Ferrari C; Baroldi P; Cavioni V; Paracchi A; Galparoli C; Romano C; Spellecchia D; Gerevini G; Crosignani PG
    J Clin Endocrinol Metab; 1988 Jan; 66(1):193-8. PubMed ID: 3275684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience.
    Arduc A; Gokay F; Isik S; Ozuguz U; Akbaba G; Tutuncu Y; Berker D; Kucukler FK; Aydin Y; Guler S
    J Endocrinol Invest; 2015 Apr; 38(4):447-53. PubMed ID: 25421155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.
    Pullan PT
    Intern Med J; 2009 Apr; 39(4):213-5. PubMed ID: 19402858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.